Cargando…

Oral Zinc Supplementation Reduces the Erythropoietin Responsiveness Index in Patients on Hemodialysis

Background: In hemodialysis (HD) patients, zinc depletion caused by inadequate intake, malabsorption, and removal by HD treatment leads to erythropoiesis-stimulating agent (ESA) hyporesponsiveness. This study investigated the effects of zinc supplementation in HD patients with zinc deficiency on cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Hiroki, Abe, Masanori, Okada, Kazuyoshi, Tei, Ritsukou, Maruyama, Noriaki, Kikuchi, Fumito, Higuchi, Terumi, Soma, Masayoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446779/ https://www.ncbi.nlm.nih.gov/pubmed/25988769 http://dx.doi.org/10.3390/nu7053783

Ejemplares similares

Randomized Controlled Trial of Darbepoetin α Versus Continuous Erythropoietin Receptor Activator Injected Subcutaneously Once Every Four Weeks in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage
por: Furukawa, Tetsuya, et al.
Publicado: (2015)

Effects of Levocarnitine on Brachial-Ankle Pulse Wave Velocity in Hemodialysis Patients: A Randomized Controlled Trial
por: Higuchi, Terumi, et al.
Publicado: (2014)

Prevalence of Zinc Deficiency in Japanese Patients on Peritoneal Dialysis: Comparative Study in Patients on Hemodialysis
por: Shimizu, Satoshi, et al.
Publicado: (2020)

Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Peritoneal Dialysis
por: Shimizu, Satoshi, et al.
Publicado: (2019)

Comparison of Clinical Trajectories before Initiation of Renal Replacement Therapy between Diabetic Nephropathy and Nephrosclerosis on the KDIGO Guidelines Heat Map
por: Abe, Masanori, et al.
Publicado: (2016)

Comparison of Sustained Hemodiafiltration with Acetate-Free Dialysate and Continuous Venovenous Hemodiafiltration for the Treatment of Critically Ill Patients with Acute Kidney Injury
por: Abe, Masanori, et al.
Publicado: (2011)

Mineral Metabolic Abnormalities and Mortality in Dialysis Patients
por: Abe, Masanori, et al.
Publicado: (2013)

Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis
por: Kobayashi, Hiroki, et al.
Publicado: (2016)

Canagliflozin Improves Erythropoiesis in Diabetes Patients with Anemia of Chronic Kidney Disease
por: Maruyama, Takashi, et al.
Publicado: (2019)

T/L-type calcium channel blocker reduces the composite ranking of relative risk according to new KDIGO guidelines in patients with chronic kidney disease
por: Abe, Masanori, et al.
Publicado: (2013)

Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
por: Munie, Stephanie, et al.
Publicado: (2021)

Effects of Zinc Acetate Hydrate Supplementation on Renal Anemia with Hypozincemia in Hemodialysis Patients
por: Sato, Eiichi, et al.
Publicado: (2022)

Effect of zinc supplementation on body mass index and serum levels of zinc and leptin in pediatric hemodialysis patients
por: El-Shazly, Ahmed Nabih, et al.
Publicado: (2015)

Effects of Levocarnitine Treatment on the Cardiac Function in Hemodialysis Patients
por: Maruyama, Takashi, et al.
Publicado: (2018)

Kinetics of Glucoregulatory Peptide Hormones during Hemodialysis with Cellulose Triacetate and Polysulfone Dialyzers in Patients with Diabetes and End-Stage Kidney Disease
por: Takao, Nobuteru, et al.
Publicado: (2023)

Adiponectin Receptor gene Polymorphisms are Associated with Kidney Function in Elderly Japanese Populations
por: Kobayashi, Hiroki, et al.
Publicado: (2019)

Effects of Zinc supplementation on serum copper to Zinc and CRP to albumin ratios in hemodialysis patients
por: Hajji, Marwa, et al.
Publicado: (2021)

Erythropoietin-producing tubercle granuloma in a hemodialysis patient
por: Satoh, Minoru, et al.
Publicado: (2013)

Obesity may be erythropoietin dose-saving in hemodialysis patients
por: El-Kannishy, Ghada M., et al.
Publicado: (2018)

Erythropoietin treatment and the risk of hip fractures in hemodialysis patients
por: Suresh, Sukanya, et al.
Publicado: (2021)

Adiponectin is not associated with renal function decline in community-dwelling elderly adults
por: Kobayashi, Hiroki, et al.
Publicado: (2018)

Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes
por: Schneider, Andreas, et al.
Publicado: (2013)

Skeletal muscle mass is associated with erythropoietin response in hemodialysis patients
por: Takata, Tomoaki, et al.
Publicado: (2021)

Erythropoietin Resistance Development in Hemodialysis Patients: The Role of Oxidative Stress
por: Joksimovic Jovic, Jovana, et al.
Publicado: (2022)

Predictors of iron versus erythropoietin responsiveness in anemic hemodialysis patients
por: Hildebrand, Sarah, et al.
Publicado: (2022)

Effects of Zinc Supplementation on Plasma Copper/Zinc Ratios, Oxidative Stress, and Immunological Status in Hemodialysis Patients
por: Guo, Chih-Hung, et al.
Publicado: (2012)

Effect of Zinc Supplementation on Renal Anemia in 5/6-Nephrectomized Rats and a Comparison with Treatment with Recombinant Human Erythropoietin
por: Feng, Hui-Lin, et al.
Publicado: (2019)

Systematic implantation of dedifferentiated fat cells ameliorated monoclonal antibody 1-22-3-induced glomerulonephritis by immunosuppression with increases in TNF-stimulated gene 6
por: Maruyama, Takashi, et al.
Publicado: (2015)

Gender Differences in Dose of Erythropoietin to Maintain Hemoglobin Target in Hemodialysis Patients
por: Coronado Daza, J. A., et al.
Publicado: (2019)

Comparing the effects of intravenous and subcutaneous Erythropoietin on blood indices in hemodialysis patients
por: Ghasemi, Faramarz, et al.
Publicado: (2019)

Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia
por: Zhu, Yifan, et al.
Publicado: (2022)

How the Duration Period of Erythropoietin Treatment Influences the Oxidative Status of Hemodialysis Patients
por: Dimitrijevic, Zorica M., et al.
Publicado: (2012)

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Bae, Myoung Nam, et al.
Publicado: (2015)

Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients
por: Agarwal, Gaurav, et al.
Publicado: (2016)

Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients
por: Rahbar, Maryam, et al.
Publicado: (2017)

Comparison of Hemoglobin Levels Before and After Hemodialysis and Their Effects on Erythropoietin Dosing and Cost
por: Sagheb, Mohammad Mahdi, et al.
Publicado: (2016)

Erythropoietin Dose and Mortality in Hemodialysis Patients: Marginal Structural Model to Examine Causality
por: Streja, Elani, et al.
Publicado: (2016)

Erythropoietin prevents dementia in hemodialysis patients: a nationwide population-based study
por: Hung, Peir-Haur, et al.
Publicado: (2019)

Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients
por: Kim, Do Hyoung, et al.
Publicado: (2021)

Lipoprotein Lipase Deficiency Arising in Type V Dyslipidemia
por: Tanaka, Sho, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_06008iqdrqn1gbrije0uidf7ni